TrialIndian journal of ophthalmology2019

Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis.

Lakshey Dudeja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.